智核生物 SmartNuclide | NEWS

SmartNuclide announced the completion of nearly RMB 100 million round B financing
2020/04/29
The kick-off meeting of phase III clinical trial of rhTSH Drug SNA001 developed by SmartNuclide was held in Suzhou
2020/02/12
SmartNuclide Biopharma Announces First Patient Treated in Phase 1/2 Clinical Trial of SNA001 for Well-Differentiated Thyroid Cancer
2019/02/12
SmartNuclide’s SNA001 Receives NMPA’s First Investigational New Drug Approval for Recombinant Human TSH
2018/10/18
Innovative Radiopharmaceutical Company SmartNuclide Closes Series Pre-A Financing
2018/03/07